LAG3 and neoplasm: Fibrinogen-like protein 1 (FGL1) is a new major ligand for LAG-3 and it has recently been demonstrated that blocking the FGL1-LAG-3 pathways results in the stimulation of tumour immunity and inhibits tumour growth (176).